...
首页> 外文期刊>Journal of plastic, reconstructive & aesthetic surgery: JPRAS >Breast lymphoma combined with postoperative acute hematopoietic disorder in an immediate breast reconstruction patient
【24h】

Breast lymphoma combined with postoperative acute hematopoietic disorder in an immediate breast reconstruction patient

机译:乳腺淋巴瘤合并术后急性造血疾病的即时乳房重建患者

获取原文
获取原文并翻译 | 示例

摘要

Primary breast lymphoma (PBL) is a type of extra-nodal Non-Hodgkin lymphoma (NHL) in which breast tissue is the primary site of malignancy. They comprise only a small percentage of all mammary malignancies and the breast is an unusual site of involvement by lymphoma.1 Lymphomas may clinically, radiological, and morphologically mimic both benign and neoplastic conditions.A 32 years old female patient found a 3 x 2 cm2 tumor in right breast 1 month before admission. Ultrasound showed 3.2 x 2.7 x 1.8 cm and 3.2 x 1.2 cm low resonance tumors in the right breast, with rich blood supply; lymph node (-). Regular blood test showed her white blood cell (WBC), red blood cell (RBC), hematocrit (HCT) were all in normal range. Her hemoglobin (Hb) level was 110 g/L. The frozen pathological result of biopsy was infiltrating ductal carcinoma and the patient received right breast resection and immediate breast reconstruction with DIEP flap. Blood loss was about 300 ml in operation. At 48 h post operation, the patient suffered dizzy and fatigue, regular blood test showed: Hb 30 g/L, WBC 5.27 x 109/L, RBC 1.02 x 1012/L, HCT 8.6%. The patient's blood type is B Rh(-) and she received blood. Her Hb level was kept stable at 73 g/L after 5u B Rh(-) RBC transfusion. While the color of the DIEP flap turned from pale into deep blue gradually since the 2nd day post operation and she received another operation to remove the flap on the 3rd day post operation. 7 days later the final pathological result turned out to be diffused large B cell lymphoma (DLBCL) (Stage: IE, IPI:0), AE1/AE3(+), ALK(-), CD20(++), CD3(diffused+), CD68(diffused+), Ki-67 75% (Figure 1). She received bone marrow biopsy to confirm the diagnosis and the stage (Figure 2), and then she was referred to the hematologist to receive chemotherapy (R-CHOP). At that time her Hb was 105 g/L.
机译:原发性乳腺淋巴瘤(PBL)是一种结外型非霍奇金淋巴瘤(NHL),其中乳腺组织是恶性肿瘤的主要部位。它们仅占所有乳腺恶性肿瘤的一小部分,并且乳房是淋巴瘤的罕见受累部位。1淋巴瘤可能在临床,影像学和形态学上均模拟良性和肿瘤性疾病。32岁的女性患者发现3 x 2 cm2入院前1个月右乳房肿瘤。超声检查显示右乳房有3.2 x 2.7 x 1.8 cm和3.2 x 1.2 cm的低共振肿瘤,血液供应丰富。淋巴结(-)。常规血液检查显示她的白细胞(WBC),红细胞(RBC),血细胞比容(HCT)均在正常范围内。她的血红蛋白(Hb)水平为110 g / L。活检的冷冻病理结果是浸润性导管癌,患者接受了右乳房切除术并立即用DIEP皮瓣进行了乳房再造。手术中失血量约为300毫升。术后48小时,患者头晕乏力,定期血液检查显示:Hb 30 g / L,WBC 5.27 x 109 / L,RBC 1.02 x 1012 / L,HCT 8.6%。患者的血型为B Rh(-),并且接受了血液治疗。 5u B Rh(-)RBC输注后,她的Hb水平稳定在73 g / L。自手术后第二天起,DIEP瓣的颜色逐渐由浅变成深蓝色,而术后第三天她接受了另一次手术以取下瓣。 7天后,最终病理结果是弥漫性大B细胞淋巴瘤(DLBCL)(阶段:IE,IPI:0),AE1 / AE3(+),ALK(-),CD20(++),CD3(diffused + ),CD68(扩散+),Ki-67 75%(图1)。她接受了骨髓活检以确认诊断和分期(图2),然后她被转介给血液学家接受化疗(R-CHOP)。那时她的血红蛋白为105 g / L。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号